Stoke Therapeutics, Inc.

Stoke Therapeutics to Host Webcast and Conference Call to Discuss First Quarter 2026 Business and Financial Updates

Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations

Stoke Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference

Stoke Therapeutics Appoints Clare Kahn, Ph.D., to its Board of Directors

The New England Journal of Medicine Publishes First Data to Demonstrate the Potential for Disease Modification in Dravet Syndrome